I do not consider my post to be 'negative', but to be factual criticisms of poor execution. The meeting showed that yes the team has the science down and right, but they also admitted they needed new management, an admission that they have screwed to pooch so far in getting the submissions done, and ignoring the FDA submission altogether. Saying they 'think' they are in fast track designation but not sure is about as stupid a comment as they can make. Ambiguity coupled with silence is their forte.